Logo image
Factors associated with microalbuminuria in 7,549 children and adolescents with type 1 diabetes in the T1D Exchange clinic registry
Journal article   Open access   Peer reviewed

Factors associated with microalbuminuria in 7,549 children and adolescents with type 1 diabetes in the T1D Exchange clinic registry

Mark Daniels, Stephanie N DuBose, David M Maahs, Roy W Beck, Larry A Fox, Rose Gubitosi-Klug, Lori M Laffel, Kellee M Miller, Heather Speer, William V Tamborlane, …
Diabetes care, Vol.36(9), pp.2639-2645
09/2013
DOI: 10.2337/dc12-2192
PMCID: PMC3747908
PMID: 23610082
url
https://doi.org/10.2337/dc12-2192View
Published (Version of record) Open Access

Abstract

To examine factors associated with clinical microalbuminuria (MA) diagnosis in children and adolescents in the T1D Exchange clinic registry. T1D Exchange participants <20 years of age with type 1 diabetes ≥ 1 year and urinary albumin-to-creatinine ratio (ACR) measured within the prior 2 years were included in the analysis. MA diagnosis required all of the following: 1) a clinical diagnosis of sustained MA or macroalbuminuria, 2) confirmation of MA diagnosis by either the most recent ACR being ≥ 30 mg/g or current treatment with an ACE inhibitor (ACEI) or angiotensin receptor blocker (ARB), and 3) no known cause for nephropathy other than diabetes. Logistic regression was used to assess factors associated with MA. MA was present in 329 of 7,549 (4.4%) participants, with a higher frequency associated with longer diabetes duration, higher mean glycosylated hemoglobin (HbA1c) level, older age, female sex, higher diastolic blood pressure (BP), and lower BMI (P ≤ 0.01 for each in multivariate analysis). Older age was most strongly associated with MA among participants with HbA1c ≥ 9.5% (≥ 80 mmol/mol). MA was uncommon (<2%) among participants with HbA1c <7.5% (<58 mmol/mol). Of those with MA, only 36% were receiving ACEI/ARB treatment. Our results emphasize the importance of good glycemic and BP control, particularly as diabetes duration increases, in order to reduce the risk of nephropathy. Since age and diabetes duration are important nonmodifiable factors associated with MA, the importance of routine screening is underscored to ensure early diagnosis and timely treatment of MA.
Glycated Hemoglobin A - metabolism Humans Risk Factors Child, Preschool Diabetes Mellitus, Type 1 - metabolism Male Young Adult Albuminuria - diagnosis Adolescent Adult Female Albuminuria - metabolism Blood Pressure - physiology Blood Glucose - metabolism Child

Details

Metrics

Logo image